Follow
Carlos López Solarat
Carlos López Solarat
Verified email at uvigo.es
Title
Cited by
Cited by
Year
ALMS1 regulates TGF-β signaling and morphology of primary cilia
M Álvarez-Satta, M Lago-Docampo, B Bea-Mascato, C Solarat, ...
Frontiers in Cell and Developmental Biology 9, 623829, 2021
192021
Allelic overload and its clinical modifier effect in Bardet-Biedl syndrome
I Perea-Romero, C Solarat, F Blanco-Kelly, I Sanchez-Navarro, ...
NPJ Genomic Medicine 7 (1), 41, 2022
132022
Prevalent ALMS1 Pathogenic Variants in Spanish Alström Patients
B Bea-Mascato, C Solarat, I Perea-Romero, T Jaijo, F Blanco-Kelly, ...
Genes 12 (2), 282, 2021
52021
Common variation in EDN1 regulatory regions highlights the role of PPARγ as a key regulator of Endothelin in vitro
M Lago-Docampo, C Solarat, L Méndez-Martínez, A Baloira, D Valverde
Frontiers in Cardiovascular Medicine 9, 823133, 2022
32022
Clinical and molecular diagnosis of Bardet-Biedl syndrome (BBS)
C Solarat, D Valverde
Methods in Cell Biology 176, 125-137, 2023
12023
Phosphoproteomic profiling highlights CDC42 and CDK2 as key players in the regulation of the TGF-β pathway in ALMS1 and BBS1 knockout models
B Bea-Mascato, G Giudice, I Pinheiro-de-Sousa, C Solarat, E Petsalaki, ...
bioRxiv, 2022.11. 04.514246, 2022
12022
ALMS1 Regulates TGF-β Signaling and Morphology of Primary Cilia.
M Lago-Docampo, B Bea-Mascato, C Solarat, S Castro-Sŕ, D Valverde
Frontiers in Cell and Developmental Biology, NA-NA, 2021
2021
Analysis of endothelin-1 (EDN-1) UTR regions
C Solarat, M Lago-Docampo, L Méndez-Martínez, A Baloira, D Valverde
Universidad de Vigo, 2021
2021
Prevalent ALMS1 Pathogenic Variants in Spanish Alström Patients. Genes 2021, 12, 282
B Bea-Mascato, C Solarat, I Perea-Romero, T Jaijo, F Blanco-Kelly, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
High Prevalence Mutations in ALMS1 in Spanish Alström Patients
BB Mascato, CL Solarat, IP Romeo, T Jaijo, FB Kelly, C Ayuso, ...
2020
The system can't perform the operation now. Try again later.
Articles 1–10